If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
ALENDRONATE PLUS D3 - DRLA 70 mg/140 microgram alendronate (as sodium) and colecalciferol 140 microgram (5600 IU) tablet blister pack AUST R: 206936Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427306107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|
ALENDRONATE PLUS D3 - DRLA 70 mg/70 microgram alendronate (as sodium) and colecalciferol 70 microgram (2800 IU) tablet blister pack AUST R: 206930Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427306107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|
ALENDRONATE PLUS D3 70 mg/140 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack AUST R: 308733Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427 306 107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|
ALENDRONATE PLUS D3 70 mg/70 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 70 microgram (2800 IU) tablet blister pack AUST R: 308732Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427306107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|
ALENDRONATE PLUS D3 SANDOZ 70 mg/140 microgram alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack AUST R: 206935Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427306107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|
ALENDRONATE PLUS D3 SANDOZ 70 mg/70 microgram alendronate (as sodium) and colecalciferol 70 mg/70 microgram (2800 IU) tablet blister pack AUST R: 206929Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427306107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|
FONATPLUS 70 mg/140 ug alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack AUST R: 206931Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427306107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
|
FONATPLUS 70 mg/70 ug alendronate (as sodium) and colecalciferol 70 mg/70 microgram (2800 IU) tablet blister pack AUST R: 206937Active ingredients:
alendronate sodium
colecalciferol
Dosage form: Tablet, uncoated
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Phone: 0427306107
|
Deletion from market:
28 Feb 2023
|
Shortage status: Discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
|